Associations between sleep, cortisol regulation, and diet: Possible implications for the risk of Alzheimer disease

Advances in Nutrition

Volumn 7, Issue 4, 2016, Pages 679-689

  Pistollato, Francesca ^a   Cano, Sandra Sumalla ^a,b,c   Elio, Iñaki ^a,b,c   Vergara, Manuel Masias ^a,d   Giampieri, Francesca ^a,e   Battino, Maurizio ^a,e  

^a Center for Nutrition and Health   (Spain)

^b International Ibero American University   (Mexico)

^c Ibero American University Foundation   (Spain)

^d International Ibero American University (UNINI)   (Puerto Rico)

^e UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Acidosis; Alzheimer disease; Cortisol; Glymphatic system; Hippocampus; Nutritional interventions; Sleep; Supplements; Western diet

Indexed keywords

AMYLOID BETA PROTEIN; HYDROCORTISONE;

ALZHEIMER DISEASE; ANIMAL; BRAIN; CIRCADIAN RHYTHM; COGNITIVE DYSFUNCTION; DIET THERAPY; FEEDING BEHAVIOR; HUMAN; METABOLISM; SECRETION (PROCESS); SLEEP; SLEEP DISORDER; WAKEFULNESS;

ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; BRAIN; CIRCADIAN RHYTHM; COGNITIVE DYSFUNCTION; FEEDING BEHAVIOR; HUMANS; HYDROCORTISONE; SLEEP; SLEEP WAKE DISORDERS; WAKEFULNESS;

EID: 84981225789     PISSN: 21618313     EISSN: 21565376     Source Type: Journal    
DOI: 10.3945/an.115.011775     Document Type: Review

References (157)

1. Alzheimer's Disease International [Internet]. World Alzheimer Report; 2009 [cited 2015 Mar 19]. Available from:http://www.alz.co.uk/research/files/WorldAlzheimerReport.pdf.
2. Alzheimer's Association [Internet]. Alzheimer'sDisease Factsand Figures; 2013 [cited 2015 Mar 19]. Available from:http://www.alz.org/downloads/facts_figures_2013.pdf.
3. Daulatzai MA. Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease. Neurochem Res 2012;37:2627-58.
4. Selkoe DJ. Resolving controversies on the path to Alzheimer's therapeutics. Nat Med 2011;17:1060-5.
5. Kevei É, Hoppe T. Ubiquitin sets the timer: impacts on aging and longevity. Nat Struct Mol Biol 2014;21:290-2.
6. Deger JM, Gerson JE, Kayed R. The interrelationship of proteasome impairment and oligomeric intermediates in neurodegeneration. Aging Cell 2015;14:715-24.
7. Wolfe DM, Lee JH, Kumar A, Lee S, Orenstein SJ, Nixon RA. Autophagy failure in Alzheimer's disease and the role of defective lysosomal acidification. Eur J Neurosci 2013;37:1949-61.
8. Nixon RA, Yang DS. Autophagy failure in Alzheimer's disease- locating the primary defect. Neurobiol Dis 2011;43:38-45.
9. Hol EM, Fischer DF, Ovaa H, Scheper W. Ubiquitin proteasome system as a pharmacological target in neurodegeneration. Expert Rev Neurother 2006;6:1337-47.
10. Kyrtsos CR, Baras JS. Modeling the role of the glymphatic pathway and cerebral blood vessel properties in Alzheimer's disease pathogenesis. PLoS One 2015;10:e0139574.
11. Tarasoff-Conway JM, Carare RO, Osorio RS, Glodzik L, Butler T, Fieremans E, Axel L, Rusinek H, Nicholson C, Zlokovic BV, et al. Clearance systems in the brain-implications for Alzheimer disease. Nat Rev Neurol 2015;11:457-70.
12. Jessen NA, Munk AS, Lundgaard I, Nedergaard M. The glymphatic system: a beginner's guide. Neurochem Res 2015;40:2583-99.
13. Lim MM, Gerstner JR, Holtzman DM. The sleep-wake cycle and Alzheimer's disease: what do we know? Neurodegener Dis Manag 2014;4:351-62.
14. Videnovic A, Lazar AS, Barker RA, Overeem S. 'The clocks that time us'-circadian rhythms in neurodegenerative disorders. Nat Rev Neurol 2014;10:683-93.
15. Peter-Derex L, Yammine P, Bastuji H, Croisile B. Sleep and Alzheimer's disease. Sleep Med Rev 2015;19:29-38.
16. Mendelsohn AR, Larrick JW. Sleep facilitates clearance of metabolites from the brain: glymphatic function in aging and neurodegenerative diseases. Rejuvenation Res 2013;16:518-23.
17. Berrino F. [Western diet and Alzheimer's disease] Epidemiol Prev 2002;26:107-15 (in Italian).
18. Oboudiyat C, Glazer H, Seifan A, Greer C, Isaacson RS. Alzheimer's disease. Semin Neurol 2013;33:313-29.
19. Nicolia V, Lucarelli M, Fuso A. Environment, epigenetics and neuro-degeneration: focus on nutrition in Alzheimer's disease. Exp Gerontol 2015;68:8-12.
20. Pistollato F, Battino M. Role of plant-based diets in the prevention and regression of metabolic syndrome and neurodegenerative diseases. Trends Food Sci Technol 2014;40:62-81.
21. Singh RB, Gupta S, Dherange P, De Meester F, Wilczynska A, Alam SE, Pella D, Wilson DW. Metabolic syndrome: a brain disease. Can J Physiol Pharmacol 2012;90:1171-83.
22. Maurer M, Riesen W, Muser J, Hulter HN, Krapf R. Neutralization of Western diet inhibits bone resorption independently of K intake and reduces cortisol secretion in humans. Am J Physiol Renal Physiol 2003;284:F32-40.
23. Popp J, Wolfsgruber S, Heuser I, Peters O, Hull M, Schroder J, Moller HJ, Lewczuk P, Schneider A, Jahn H, et al. Cerebrospinal fluid cortisol and clinical disease progression in MCI and dementia of Alzheimer's type. Neurobiol Aging 2015;36:601-7.
24. Backhaus J, Junghanns K, Hohagen F. Sleep disturbances are correlated with decreased morning awakening salivary cortisol. Psycho-neuroendocrinology 2004;29:1184-91.
25. Leproult R, Copinschi G, Buxton O, Van Cauter E. Sleep loss results in an elevation of cortisol levels the next evening. Sleep 1997;20:865-70.
26. Chai CK. The genetics of Alzheimer's disease. Am J Alzheimers Dis Other Demen 2007;22:37-41.
27. Gatz M, Reynolds CA, Fratiglioni L, Johansson B, Mortimer JA, Berg S, Fiske A, Pedersen NL. Role of genes and environments for explaining Alzheimer disease. Arch Gen Psychiatry 2006;63:168-74.
28. Rossor MN, Fox NC, Freeborough PA, Harvey RJ. Clinical features of sporadic and familial Alzheimer's disease. Neurodegeneration 1996;5:393-7.
29. Willette AA, Johnson SC, Birdsill AC, Sager MA, Christian B, Baker LD, Craft S, Oh J, Statz E, Hermann BP, et al. Insulin resistance predicts brain amyloid deposition in late middle-aged adults. Alzheimers Dement 2014;11:504-10.
30. Kenna H, Hoeft F, Kelley R, Wroolie T, DeMuth B, Reiss A, Rasgon N. Fasting plasma insulin and the default mode network in women at risk for Alzheimer's disease. Neurobiol Aging 2013;34:641-9.
31. Cherbuin N, Sachdev P, Anstey KJ. Higher normal fasting plasma glucose is associated with hippocampal atrophy: the PATH Study. Neurology 2012;79:1019-26.
32. Blom K, Emmelot-Vonk MH, Koek HL. The influence of vascular risk factors on cognitive decline in patients with dementia: a systematic review. Maturitas 2013;76:113-7.
33. Ferreira ST, Clarke JR, Bomfim TR, De Felice FG. Inflammation, defective insulin signaling, and neuronal dysfunction in Alzheimer's disease. Alzheimers Dement 2014;10(1 Suppl):S76-83.
34. Morris JK, Vidoni ED, Honea RA, Burns JM; Alzheimer's Disease Neuroimaging Initiative. Impaired glycemia increases disease progression in mild cognitive impairment. Neurobiol Aging 2014;35:585-9.
35. Rosendorff C, Beeri MS, Silverman JM. Cardiovascular risk factors for Alzheimer's disease. Am J Geriatr Cardiol 2007;16:143-9.
36. Muqtadar H, Testai FD, Gorelick PB. The dementia of cardiac disease. Curr Cardiol Rep 2012;14:732-40.
37. Román GC. Vascular dementia prevention: a risk factor analysis. Cerebrovasc Dis 2005;20 (Suppl 2):91-100.
38. Polidori MC, Mariani E, Mecocci P, Nelles G. Congestive heart failure and Alzheimer's disease. Neurol Res 2006;28:588-94.
39. de la Torre JC. How do heart disease and stroke become risk factors for Alzheimer's disease? Neurol Res 2006;28:637-44.
40. Lee TA, Wolozin B, Weiss KB, Bednar MM. Assessment of the emergence of Alzheimer's disease following coronary artery bypass graft surgery or percutaneous transluminal coronary angioplasty. J Alzheimers Dis 2005;7:319-24.
41. Zulli R, Nicosia F, Borroni B, Agosti C, Prometti P, Donati P, De Vecchi M, Turini D, Romanelli G, Grassi V, et al. Increased prevalence of silent myocardial ischaemia and severe ventricular arrhythmias in untreated patients with Alzheimer's disease and mild cognitive impairment without overt coronary artery disease. Clin Neurol Neurosurg 2008;110:791-6.
42. Lima LM, Carvalho M, Ferreira CN, Fernandes AP, Neto CP, Garcia JC, Reis HJ, Janka Z, Palotas A, Sousa M. Atheromatosis extent in coronary artery disease is not correlated with apolipoprotein-E polymorphism and its plasma levels, but associated with cognitive decline. Curr Alzheimer Res 2010;7:556-63.
43. Roberts RO, Knopman DS, Geda YE, Cha RH, Roger VL, Petersen RC. Coronary heart disease is associated with non-amnestic mild cognitive impairment. Neurobiol Aging 2010;31:1894-902.
44. Koschack J, Irle E. Small hippocampal size in cognitively normal subjects with coronary artery disease. Neurobiol Aging 2005;26:865-71.
45. Ikram MA, van Oijen M, de Jong FJ, Kors JA, Koudstaal PJ, Hofman A, Witteman JC, Breteler MM. Unrecognized myocardial infarction in relation to risk of dementia and cerebral small vessel disease. Stroke 2008;39:1421-6.
46. Reitz C, Brickman AM, Luchsinger JA, Wu WE, Small SA, Tang MX. Frequency of subclinical heart disease in elderly persons with dementia. Am J Geriatr Cardiol 2007;16:183-8.
47. Daulatzai MA. Death by a thousand cuts in Alzheimer's disease: hypoxia the prodrome. Neurotox Res 2013;24:216-43.
48. Bunch TJ, Weiss JP, Crandall BG, May HT, Bair TL, Osborn JS, Anderson JL, Muhlestein JB, Horne BD, Lappe DL, et al. Atrial fibrillation is independently associated with senile, vascular, and Alzheimer's dementia. Heart Rhythm 2010;7:433-7.
49. Rusanen M, Kivipelto M, Levälahti E, Laatikainen T, Tuomilehto J, Soininen H, Ngandu T. Heart diseases and long-term risk of dementia and Alzheimer's disease: a population-based CAIDE study. J Alzheimers Dis 2014;42:183-91.
50. Dai Y, Kamal MA. Fighting Alzheimer's disease and type 2 diabetes: pathological links and treatment strategies. CNS Neurol Disord Drug Targets 2014;13:271-82.
51. de la Monte SM, Tong M. Brain metabolic dysfunction at the core of Alzheimer's disease. Biochem Pharmacol 2014;88:548-59.
52. Mattson MP. Will caloric restriction and folate protect against AD and PD? Neurology 2003;60:690-5.
53. Cipriani G, Lucetti C, Danti S, Nuti A. Sleep disturbances and dementia. Psychogeriatrics 2015;15:65-74.
54. Guarnieri B, Adorni F, Musicco M, Appollonio I, Bonanni E, Caffarra P, Caltagirone C, Cerroni G, Concari L, Cosentino FI, et al. Prevalence of sleep disturbances in mild cognitive impairment and dementing disorders: a multicenter Italian clinical cross-sectional study on 431 patients. Dement Geriatr Cogn Disord 2012;33:50-8.
55. Pistacchi M, Gioulis M, Contin F, Sanson F, Marsala SZ. Sleep disturbance and cognitive disorder: epidemiological analysis in a cohort of 263 patients. Neurol Sci 2014;35:1955-62.
56. Daulatzai MA. Evidence of neurodegeneration in obstructive sleep apnea: relationship between obstructive sleep apnea and cognitive dys-function in the elderly. J Neurosci Res 2015;93:1778-94.
57. Buxton OM, Pavlova M, Reid EW, Wang W, Simonson DC, Adler GK. Sleep restriction for 1 week reduces insulin sensitivity in healthy men. Diabetes 2010;59:2126-33.
58. Donga E, van Dijk M, van Dijk JG, Biermasz NR, Lammers GJ, van Kralingen KW, Corssmit EP, Romijn JA. A single night of partial sleep deprivation induces insulin resistance in multiple metabolic pathways in healthy subjects. J Clin Endocrinol Metab 2010;95:2963-8.
59. McCleery J, Cohen DA, Sharpley AL. Pharmacotherapies for sleep disturbances in Alzheimer's disease. Cochrane Database Syst Rev 2014;3: CD009178.
60. Wade AG, Farmer M, Harari G, Fund N, Laudon M, Nir T, FrydmanMarom A, Zisapel N. Add-on prolonged-release melatonin for cognitive function and sleep in mild to moderate Alzheimer's disease: a 6-month, randomized, placebo-controlled, multicenter trial. Clin Interv Aging 2014;9:947-61.
61. Billioti de Gage S, Moride Y, Ducruet T, Kurth T, Verdoux H, Tournier M, Pariente A, Begaud B. Benzodiazepine use and risk of Alzheimer's disease: case-control study. BMJ 2014;349:g5205.
62. Bocti C, Roy-Desruisseaux J, Hudon C, Roberge P. Benzodiazepine and dementia: a time for reflection. Maturitas 2013;75:105-6.
63. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Benveniste H, Vates GE, Deane R, Goldman SA, et al. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med 2012;4:147ra111.
64. Xie L, Kang H, Xu Q, Chen MJ, Liao Y, Thiyagarajan M, O'Donnell J, Christensen DJ, Nicholson C, Iliff JJ, et al. Sleep drives metabolite clearance from the adult brain. Science 2013;342:373-7.
65. Kress BT, Iliff JJ, Xia M, Wang M, Wei HS, Zeppenfeld D, Xie L, Kang H, Xu Q, Liew JA, et al. Impairment of paravascular clearance pathways in the aging brain. Ann Neurol 2014;76:845-61.
66. Iliff JJ, Lee H, Yu M, Feng T, Logan J, Nedergaard M, Benveniste H. Brain-wide pathway for waste clearance captured by contrast-enhanced MRI. J Clin Invest 2013;123:1299-309.
67. Yang L, Kress BT, Weber HJ, Thiyagarajan M, Wang B, Deane R, Benveniste H, Iliff JJ, Nedergaard M. Evaluating glymphatic pathway function utilizing clinically relevant intrathecal infusion of CSF tracer. J Transl Med 2013;11:107.
68. Wostyn P, Van Dam D, Audenaert K, Killer HE, De Deyn PP, De Groot V. A new glaucoma hypothesis: a role of glymphatic system dysfunction. Fluids Barriers CNS 2015;12:16.
69. McKinnon SJ. Glaucoma: ocular Alzheimer's disease? Front Biosci 2003;8:s1140-56.
70. Guo L, Salt TE, Luong V, Wood N, Cheung W, Maass A, Ferrari G, Russo-Marie F, Sillito AM, Cheetham ME, et al. Targeting amyloid-beta in glaucoma treatment. Proc Natl Acad Sci USA 2007;104:13444-9.
71. Lucey BP, Bateman RJ. Amyloid-beta diurnal pattern: possible role of sleep in Alzheimer's disease pathogenesis. Neurobiol Aging 2014;35 Suppl 2:S29-34.
72. Ju YE, Lucey BP, Holtzman DM. Sleep and Alzheimer disease pathology-a bidirectional relationship. Nat Rev Neurol 2014;10:115-9.
73. Kang JE, Cirrito JR, Dong H, Csernansky JG, Holtzman DM. Acute stress increases interstitial fluid amyloid-beta via corticotropin-releasing factor and neuronal activity. Proc Natl Acad Sci USA 2007;104:10673-8.
74. Kang JE, Lim MM, Bateman RJ, Lee JJ, Smyth LP, Cirrito JR, Fujiki N, Nishino S, Holtzman DM. Amyloid-beta dynamics are regulated by orexin and the sleep-wake cycle. Science 2009;326:1005-7.
75. Gilestro GF, Tononi G, Cirelli C. Widespread changes in synaptic markers as a function of sleep and wakefulness in Drosophila. Science 2009;324:109-12.
76. Huang Y, Potter R, Sigurdson W, Santacruz A, Shih S, Ju YE, Kasten T, Morris JC, Mintun M, Duntley S, et al. Effects of age and amyloid deposition on Abeta dynamics in the human central nervous system. Arch Neurol 2012;69:51-8.
77. Lee H, Xie L, Yu M, Kang H, Feng T, Deane R, Logan J, Nedergaard M, Benveniste H. The effect of body posture on brain glymphatic transport. J Neurosci 2015;35:11034-44.
78. Abel T, Havekes R, Saletin JM, Walker MP. Sleep, plasticity and memory from molecules to whole-brain networks. Curr Biol 2013;23: R774-88.
79. Manning EN, Macdonald KE, Leung KK, Young J, Pepple T, Lehmann M, Zuluaga MA, Cardoso MJ, Schott JM, Ourselin S, et al. Differential hippocampal shapes in posterior cortical atrophy patients: a comparison with control and typical AD subjects. Hum Brain Mapp 2015;36:5123-36.
80. Kotrotsou A, Schneider JA, Bennett DA, Leurgans SE, Dawe RJ, Boyle PA, Golak T, Arfanakis K. Neuropathologic correlates of regional brain volumes in a community cohort of older adults. Neurobiol Aging 2015;36:2798-805.
81. Ricci S, Fuso A, Ippoliti F, Businaro R. Stress-induced cytokines and neuronal dysfunction in Alzheimer's disease. J Alzheimers Dis 2012; 28:11-24.
82. Elcombe EL, Lagopoulos J, Duffy SL, Lewis SJ, Norrie L, Hickie IB, Naismith SL. Hippocampal volume in older adults at risk of cognitive decline: the role of sleep, vascular risk, and depression. J Alzheimers Dis 2015;44:1279-90.
83. Joo EY, Kim H, Suh S, Hong SB. Hippocampal substructural vulnerability to sleep disturbance and cognitive impairment in patients with chronic primary insomnia: magnetic resonance imaging morphometry. Sleep 2014;37:1189-98.
84. Ming GL, Song H. Adult neurogenesis in the mammalian central nervous system. Annu Rev Neurosci 2005;28:223-50.
85. Eriksson PS, Perfilieva E, Bjork-Eriksson T, Alborn AM, Nordborg C, Peterson DA, Gage FH. Neurogenesis in the adult human hippocampus. Nat Med 1998;4:1313-7.
86. Gould E. How widespread is adult neurogenesis in mammals? Nat Rev Neurosci 2007;8:481-8.
87. Meerlo P, Mistlberger RE, Jacobs BL, Heller HC, McGinty D. New neurons in the adult brain: the role of sleep and consequences of sleep loss. Sleep Med Rev 2009;13:187-94.
88. Fotuhi M, Do D, Jack C. Modifiable factors that alter the size of the hippocampus with ageing. Nat Rev Neurol 2012;8:189-202.
89. Martin PA, Crump MH. The adrenal gland: Ames (IA): Iowa State Press, 2003.
90. Fries E, Dettenborn L, Kirschbaum C. The cortisol awakening response (CAR): facts and future directions. Int J Psychophysiol 2009; 72:67-73.
91. Tortosa-Martínez J, Clow A, Caus-Pertegaz N, González-Caballero G, Abellán-Miralles I, Saenz MJ. Exercise Increases the Dynamics of Diurnal Cortisol Secretion and Executive Function in People With Amnestic Mild Cognitive Impairment. J Aging Phys Act 2015;23:550-8.
92. Souza-Talarico JN, Chaves EC, Lupien SJ, Nitrini R, Caramelli P. Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimer's disease subjects. J Alzheimers Dis 2010;19:839-48.
93. Peavy GM, Santiago DP, Edland SD. Subjective memory complaints are associated with diurnal measures of salivary cortisol in cognitively intact older adults. Am J Geriatr Psychiatry 2013;21:925-8.
94. Beluche I, Carriere I, Ritchie K, Ancelin ML. A prospective study of diurnal cortisol and cognitive function in community-dwelling elderly people. Psychol Med 2010;40:1039-49.
95. Lee BK, Glass TA, Wand GS, McAtee MJ, Bandeen-Roche K, Bolla KI, Schwartz BS. Apolipoprotein e genotype, cortisol, and cognitive function in community-dwelling older adults. Am J Psychiatry 2008;165: 1456-64.
96. Souza-Talarico JN, Caramelli P, Nitrini R, Chaves EC. Effect of cortisol levels on working memory performance in elderly subjects with Alzheimer's disease. Arq Neuropsiquiatr 2008;66 3B:619-24.
97. Wahbeh H, Kishiyama SS, Zajdel D, Oken BS. Salivary cortisol awakening response in mild Alzheimer disease, caregivers, and noncare-givers. Alzheimer Dis Assoc Disord 2008;22:181-3.
98. Aboulafia-Brakha T, Suchecki D, Gouveia-Paulino F, Nitrini R, Ptak R. Cognitive-behavioural group therapy improves a psychophysiological marker of stress in caregivers of patients with Alzheimer'sdisease. Aging Ment Health 2014;18:801-8.
99. Wolf OT, Convit A, Thorn E, de Leon MJ. Salivary cortisol day profiles in elderly with mild cognitive impairment. Psychoneuroendocrinology 2002;27:777-89.
100. Arsenault-Lapierre G, Chertkow H, Lupien S. Seasonal effects on cortisol secretion in normal aging, mild cognitive impairment and Alzheimer's disease. Neurobiol Aging 2010;31:1051-4.
101. Magri F, Cravello L, Barili L, Sarra S, Cinchetti W, Salmoiraghi F, Micale G, Ferrari E. Stress and dementia: the role of the hypothalamicpituitary-adrenal axis. Aging Clin Exp Res 2006;18:167-70.
102. Duong M, Cohen JI, Convit A. High cortisol levels are associated with low quality food choice in type 2 diabetes. Endocrine 2012; 41:76-81.
103. Knoops AJ, Gerritsen L, van der Graaf Y, Mali WP, Geerlings MI. Basal hypothalamic pituitary adrenal axis activity and hippocampal volumes: the SMART-Medea study. Biol Psychiatry 2010;67: 1191-8.
104. McEwen BS. The neurobiology of stress: from serendipity to clinical relevance. Brain Res 2000;886:172-89.
105. Huang CW, Lui CC, Chang WN, Lu CH, Wang YL, Chang CC. Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease. J Clin Neurosci 2009;16:1283-6.
106. Lupien SJ, de Leon M, de Santi S, Convit A, Tarshish C, Nair NP, Thakur M, McEwen BS, Hauger RL, Meaney MJ. Cortisol levels during human aging predict hippocampal atrophy and memory deficits. Nat Neurosci 1998;1:69-73.
107. Lehallier B, Essioux L, Gayan J, Alexandridis R, Nikolcheva T, WyssCoray T, Britschgi M; Alzheimer's Disease Neuroimaging Initiative. Combined Plasma and Cerebrospinal Fluid Signature for the Prediction of Midterm Progression From Mild Cognitive Impairment to Alzheimer Disease. JAMA Neurol 2015;14:1-10.
108. Greendale GA, Kritz-Silverstein D, Seeman T, Barrett-Connor E. Higher basal cortisol predicts verbal memory loss in postmenopausal women: Rancho Bernardo Study. J Am Geriatr Soc 2000;48:1655-8.
109. Leonard BE. Inflammation, depression and dementia: are they connected? Neurochem Res 2007;32:1749-56.
110. Starkman MN, Giordani B, Berent S, Schork MA, Schteingart DE. Elevated cortisol levels in Cushing's disease are associated with cognitive decrements. Psychosom Med 2001;63:985-93.
111. Notarianni E. Hypercortisolemia and glucocorticoid receptor-signaling insufficiency in Alzheimer's disease initiation and development. Curr Alzheimer Res 2013;10:714-31.
112. Catania C, Sotiropoulos I, Silva R, Onofri C, Breen KC, Sousa N, Almeida OF. The amyloidogenic potential and behavioral correlates of stress. Mol Psychiatry 2009;14:95-105.
113. Lucassen PJ, Pruessner J, Sousa N, Almeida OF, Van Dam AM, Rajkowska G, Swaab DF, Czeh B. Neuropathology of stress. Acta Neuropathol 2014; 127:109-35.
114. Baglietto-Vargas D, Medeiros R, Martinez-Coria H, LaFerla FM, Green KN. Mifepristone alters amyloid precursor protein processing to preclude amyloid beta and also reduces tau pathology. Biol Psychiatry 2013;74:357-66.
115. Murialdo G, Barreca A, Nobili F, Rollero A, Timossi G, Gianelli MV, Copello F, Rodriguez G, Polleri A. Dexamethasone effects on cortisol secretion in Alzheimer's disease: some clinical and hormonal features in suppressor and nonsuppressor patients. J Endocrinol Invest 2000; 23:178-86.
116. Wang Y, Li M, Tang J, Song M, Xu X, Xiong J, Li J, Bai Y. Glucocorticoids facilitate astrocytic amyloid-beta peptide deposition by increasing the expression of APP and BACE1 and decreasing the expression of amyloid-beta-degrading proteases. Endocrinology 2011; 152:2704-15.
117. Zhao J, O'Connor T, Vassar R. The contribution of activated astrocytes to Abeta production: implications for Alzheimer's disease pathogenesis. J Neuroinflammation 2011;8:150.
118. Kanoski SE, Davidson TL. Western diet consumption and cognitive impairment: links to hippocampal dysfunction and obesity. Physiol Behav 2011;103:59-68.
119. Kim HH, Kim YJ, Lee SY, Jeong DW, Lee JG, Yi YH, Cho YH, Choi EJ, Kim HJ. Interactive effects of an isocaloric high-protein diet and resistance exercise on body composition, ghrelin, and metabolic and hormonal parameters in untrained young men: A randomized clinical trial. J Diabetes Investig 2014;5:242-7.
120. Manzanares N, Monseny R, Ortega L, Montalvo I, Franch J, GutierrezZotes A, Reynolds RM, Walker BR, Vilella E, Labad J. Unhealthy lifestyle in early psychoses: the role of life stress and the hypothalamic-pituitary-adrenal axis. Psychoneuroendocrinology 2014;39:1-10.
121. Heaney JL, Phillips AC, Carroll D. Aging, health behaviors, and the diurnal rhythm and awakening response of salivary cortisol. Exp Aging Res 2012;38:295-314.
122. Dallman MF, Pecoraro N, Akana SF, La Fleur SE, Gomez F, Houshyar H, Bell ME, Bhatnagar S, Laugero KD, Manalo S. Chronic stress and obesity: a new view of "comfort food". Proc Natl Acad Sci USA 2003; 100:11696-701.
123. Cordain L, Eaton SB, Sebastian A, Mann N, Lindeberg S, Watkins BA, O'Keefe JH, Brand-Miller J. Origins and evolution of the Western diet: health implications for the 21st century. Am J Clin Nutr 2005;81:341-54.
124. Robey IF. Examining the relationship between diet-induced acidosis and cancer. Nutr Metab (Lond) 2012;9:72.
125. Jehle S, Krapf R. Effects of acidogenic diet forms on musculoskeletal function. J Nephrol 2010;23(Suppl 16):S77-84.
126. Fang B, Wang D, Huang M, Yu G, Li H. Hypothesis on the relationship between the change in intracellular pH and incidence of sporadic Alzheimer's disease or vascular dementia. Int J Neurosci 2010;120: 591-5.
127. Basurto-Islas G, Grundke-Iqbal I, Tung YC, Liu F, Iqbal K. Activation of asparaginyl endopeptidase leads to Tau hyperphosphorylation in Alzheimer disease. J Biol Chem 2013;288:17495-507.
128. Pirchl M, Marksteiner J, Humpel C. Effects of acidosis on brain capillary endothelial cells and cholinergic neurons: relevance to vascular dementia and Alzheimer's disease. Neurol Res 2006;28:657-64.
129. Karim Z, Attmane-Elakeb A, Bichara M. Renal handling of NH4+ in relation to the control of acid-base balance by the kidney. J Nephrol 2002;15 Suppl 5:S128-34.
130. McCarty MF. Acid-base balance may influence risk for insulin resistance syndrome by modulating cortisol output. Med Hypotheses 2005;64:380-4.
131. Gibson EL, Checkley S, Papadopoulos A, Poon L, Daley S, Wardle J. Increased salivary cortisol reliably induced by a protein-rich midday meal. Psychosom Med 1999;61:214-24.
132. Mattei J, Bhupathiraju S, Tucker KL. Higher adherence to a diet score based on American Heart Association recommendations is associated with lower odds of allostatic load and metabolic syndrome in Puerto Rican adults. J Nutr 2013;143:1753-9.
133. García-Prieto MD, Tébar FJ, Nicolás F, Larqué E, Zamora S, Garaulet M. Cortisol secretary pattern and glucocorticoid feedback sensitivity in women from a Mediterranean area: relationship with anthropometric characteristics, dietary intake and plasma fatty acid profile. Clin Endocrinol (Oxf) 2007;66:185-91.
134. Knight A, Bryan J, Wilson C, Hodgson J, Murphy K. A randomised controlled intervention trial evaluating the efficacy of a Mediterranean dietary pattern on cognitive function and psychological wellbeing in healthy older adults: the MedLey study. BMC Geriatr 2015;15:55.
135. Hao S, Dey A, Yu X, Stranahan AM. Dietary obesity reversibly induces synaptic stripping by microglia and impairs hippocampal plasticity. Brain Behav Immun 2016;51:230-9.
136. Park SH, Kim JH, Choi KH, Jang YJ, Bae SS, Choi BT, Shin HK. Hypercholesterolemia accelerates amyloid beta-induced cognitive deficits. Int J Mol Med 2013;31:577-82.
137. Spence JD, Thornton T, Muir AD, Westcott ND. The effect of flax seed cultivars with differing content of alpha-linolenic acid and lignans on responses to mental stress. J Am Coll Nutr 2003;22:494-501.
138. Komori T. The Effects of Phosphatidylserine and Omega-3 Fatty Acid-Containing Supplement on Late Life Depression. Ment Illn 2015;7:5647.
139. Rakel D. Integrative Medicine, 3rd edition: Philadelphia: Saunders Elsevier, 2012.
140. Crook TH, Tinklenberg J, Yesavage J, Petrie W, Nunzi MG, Massari DC. Effects of phosphatidylserine in age-associated memory impairment. Neurology 1991;41:644-9.
141. Richter Y, Herzog Y, Cohen T, Steinhart Y. The effect of phosphatidylserine-containing omega-3 fatty acids on memory abilities in subjects with subjective memory complaints: a pilot study. Clin Interv Aging 2010;5:313-6.
142. Vakhapova V, Cohen T, Richter Y, Herzog Y, Korczyn AD. Phosphatidylserine containing omega-3 fatty acids may improve memory abilities in non-demented elderly with memory complaints: a double-blind placebo-controlled trial. Dement Geriatr Cogn Disord 2010;29: 467-74.
143. Richter Y, Herzog Y, Lifshitz Y, Hayun R, Zchut S. The effect of soybean-derived phosphatidylserine on cognitive performance in elderly with subjective memory complaints: a pilot study. Clin Interv Aging 2013; 8:557-63.
144. Eby GA, Eby KL. Rapid recovery from major depression using magnesium treatment. Med Hypotheses 2006;67:362-70.
145. Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. The effect of magnesium supplementation on primary insomnia in elderly: a double-blind placebo-controlled clinical trial. J Res Med Sci 2012;17:1161-9.
146. Drennan MD, Kripke DF, Klemfuss HA, Moore JD. Potassium affects actigraph-identified sleep. Sleep 1991;14:357-60.
147. Rastmanesh R. Hypothetical hormonal mechanism by which potassium-rich diets benefit patients with rheumatoid arthritis. Med Hypotheses 2009;73:564-8.
148. McMorris T, Harris RC, Swain J, Corbett J, Collard K, Dyson RJ, Dye L, Hodgson C, Draper N. Effect of creatine supplementation and sleep deprivation, with mild exercise, on cognitive and psychomotor performance, mood state, and plasma concentrations of catecholamines and cortisol. Psychopharmacology (Berl) 2006;185:93-103.
149. McMorris T, Harris RC, Howard AN, Langridge G, Hall B, Corbett J, Dicks M, Hodgson C. Creatine supplementation, sleep deprivation, cortisol, melatonin and behavior. Physiol Behav 2007;90:21-8.
150. Taupin P. Neurogenesis, NSCs, pathogenesis and therapies for Alzheimer's disease. Front Biosci (Schol Ed) 2011;3:178-90.
151. Irwin RW, Brinton RD. Allopregnanolone as regenerative therapeutic for Alzheimer's disease: translational development and clinical promise. Prog Neurobiol 2014;113:40-55.
152. Brinton RD, Wang JM. Therapeutic potential of neurogenesis for prevention and recovery from Alzheimer's disease: allopregnanolone as a proof of concept neurogenic agent. Curr Alzheimer Res 2006;3: 185-90.
153. Felsenstein KM, Candelario KM, Steindler DA, Borchelt DR. Regenerative medicine in Alzheimer's disease. Transl Res 2014;163: 432-8.
154. Ngandu T, Lehtisalo J, Solomon A, Levälahti E, Ahtiluoto S, Antikainen R, Bäckman L, Hänninen T, Jula A, Laatikainen T, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet 2015;35:2255-63.
155. European Commission [Internet]. Research on Alzheimer's disease in FP6 and FP7. [cited 2015 Nov 4]. Available from:http://ec.europa.eu/health/major_chronic_diseases/diseases/dementia/index_en.htm. (fragment5)
156. JPND Research. [Internet] JPco-fuND. [cited 2015 Nov 4]. Available from: http://www.neurodegenerationresearch.eu/initiatives/jpcofund/.
157. National Institute on Aging [Internet]. Living Long & Well in the 21st Century: Strategic Directions for Research on Aging. [cited 2015 Nov 4]. Available from: https://www.nia.nih.gov/about/living-long-well-21st-century-strategic-directions-research-aging.